| Name | Title | Contact Details |
|---|---|---|
Dennis Pedersen |
Executive Vice President of Global People | Profile |
Nathalie Daste |
Executive Vice President of Global People and Corporate Affairs | Profile |
Ryan Goodrich |
Head of Learning and Development | Profile |
Keith Bernius |
Chief Financial Officer & Vice President, Business Operations | Profile |
Meera Sethi |
Country Human Resources Business Partner for Canada | Profile |
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives. With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.
SantenUSA.com - a specialty pharmaceutical offering ophthalmic products & research for retinal disorders, glaucoma, and other eye diseases.
Michigan Technology & Research Institute, LLC is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.